A. Conde

ORCID: 0000-0003-1024-0924
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Management of metastatic bone disease
  • Prostate Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Spine and Intervertebral Disc Pathology
  • Brain Metastases and Treatment
  • Radiopharmaceutical Chemistry and Applications
  • Reconstructive Surgery and Microvascular Techniques
  • Spinal Fractures and Fixation Techniques
  • Medical Imaging Techniques and Applications
  • Glioma Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Orthopedic Surgery and Rehabilitation
  • Advances in Oncology and Radiotherapy
  • Meningioma and schwannoma management
  • Reconstructive Facial Surgery Techniques
  • Cancer, Lipids, and Metabolism
  • Bone fractures and treatments
  • Lung Cancer Treatments and Mutations
  • Radiation Therapy and Dosimetry
  • Melanoma and MAPK Pathways
  • Epilepsy research and treatment
  • Head and Neck Cancer Studies
  • Head and Neck Surgical Oncology

Hospital Universitari i Politècnic La Fe
2018-2025

Leitat Technological Center
2021-2024

University of Florence
2022

Universidade Federal do Rio de Janeiro
2022

Agricultural Biotechnology Institute
2022

Biocat
2022

Bioinova (Czechia)
2022

Universidad Cardenal Herrera CEU
2021

Maharaja Yeshwantrao Hospital
2021

Hospital Universitario Ramón y Cajal
2021

Purpose To compare short-course radiotherapy (RT) (4 Gy × 5) to longer-course RT (3 10) for metastatic epidural spinal cord compression (MESCC). Patients and Methods Two-hundred three patients with MESCC poor intermediate expected survival were randomly assigned 4 5 in 1 week (n = 101) or 3 10 2 weeks 102). stratified according ambulatory status, time developing motor deficits, primary tumor type. Seventy-eight 77 patients, respectively, evaluable the end point, 1-month overall response...

10.1200/jco.2015.64.0862 article EN Journal of Clinical Oncology 2016-01-05

Abstract Background Pelvic nodal recurrences are being increasingly diagnosed with the introduction of new molecular imaging techniques, like choline and PSMA PET-CT, in restaging recurrent prostate cancer (PCa). At this moment, there no specific treatment recommendations for patients limited different locoregional approaches currently used, mostly by means metastasis-directed therapies (MDT): salvage lymph node dissection (sLND) or stereotactic body radiotherapy (SBRT). Since majority...

10.1186/s12885-020-06911-4 article EN cc-by BMC Cancer 2020-05-12
Estanislao Arana Francisco M. Kovacs Ana Royuela Beatriz Asenjo Úrsula Pérez‐Ramírez and 84 more Javier Zamora Víctor Abraira Lucía Alcázar Ana Alonso Luis Álvarez Marco Antonio Álvarez Vega Guillermo Amengual Aida Antuña Fernando Aparici Joan Bagó Andrés Barriga-Martín María Dolores Mondéjar Barrios Paloma Bas J. Begara Francisco Bravo-Rodríguez A Cabrera Carlos Casillas G. Catalán A. Conde R. de las Peñas Laura K. Diaz Diego Dualde Ana Estremera J Fenollosa Carlos Iglesias Fernández Eva Fernández Nicomedes Fernández-Baíllo Pilar Ferrer Salvador Fuster María Isabel Galarraga C. García Villar Luis García-Ferrer Maria Isabel Osorio Garcia Sara García-Duque J. Garde Andrés González‐Mandly Rafael González-Díaz A. Hernández-Fernández O. Hernando R. Hernánz A. Hervás Esther Holgado M.J. Juan Javier Lavernia A. Lazo Ana Lersundi Escarlata López Rosa Magallón-Botaya Margarita Majem Martín Antonio M. I. Martin Javier Martínez-Gómez Julia Montoya Paloma Leticia Martín-Moreno Arturo Navarro-Martín Esther Noguerón Ana Ortiz de Méndivil J.C. Palomino Juan Carlos Paniagua David Pereira Luís A. Pérez-Romasanta R. Sirera Perez Ángel R. Piñera Pilar Piñero Julio Plata‐Bello José Poblete José Ramírez Juan Antonio Repetto Daniel Rivas Héctor Roldán Fernando Ruiz José Miguel Sánchez S. Sancho Helena Sarasíbar Juan Manuel Sepúlveda-Sánchez Antonio Silvestre Beatriz Sobrino Felix Tomé-Bermejo I. Tovar María del Carmen Vallejo Vicente Vanaclocha Asunción Villanueva Joaquín Zamarro Idoya Zazpe

10.1016/j.spinee.2015.10.006 article EN The Spine Journal 2015-10-25

LifeChamps is an EU Horizon 2020 project that aims to create a digital platform enable monitoring of health-related quality life and frailty in patients with cancer over the age 65. Our primary objective assess feasibility, usability, acceptability, fidelity, adherence, safety parameters when implementing routine care. Secondary objectives involve evaluating preliminary signals efficacy cost-effectiveness indicators.

10.1016/j.soncn.2023.151437 article EN cc-by-nc-nd Seminars in Oncology Nursing 2023-05-05

Metastatic pheochromocytoma and paraganglioma (mPHEO/PGL) are frequently associated with succinate dehydrogenase B ( SDHB) mutations. Cyclophosphamide-dacarbazine-vincristine (CVD) regimen is recommended as standard chemotherapy for advanced mPHEO/PGL. There limited evidence to support the role of metronomic schemes (MS) in mPHEO/PGL treatment. We report 2 patients SDHB-related mPGL who received a consisting MS temozolomide (TMZ) high-dose lanreotide after progression on both CVD lanreotide....

10.1177/1179554918763367 article EN cc-by-nc Clinical Medicine Insights Oncology 2018-01-01

Uncertainty exists whether patients with spinal cord compression (SCC) from a highly radiosensitive tumor require decompressive surgery in addition to radiotherapy (RT). This study addressed the question by evaluating receiving RT alone for SCC myeloma.Data of 238 were retrospectively analyzed response and local control SCC. In addition, effect on motor function (improvement, no further progression, deterioration) was evaluated. Overall defined as improvement or progression dysfunction....

10.1515/raon-2016-0029 article EN cc-by-nc-nd Radiology and Oncology 2016-07-19

Abstract Background Patients with metastatic spinal cord compression (MSCC) and favorable survival prognoses can benefit from radiation doses greater than 30Gy in 10 fractions terms of improved local progression-free (LPFS) overall (OS). Methods/design This prospective study mainly investigates LPFS after precision radiotherapy (volumetric modulated arc therapy or stereotactic body radiotherapy) 18 × 2.33Gy 3.5 weeks. is defined as freedom progression motor deficits during an in-field...

10.1186/s12885-019-6390-x article EN cc-by BMC Cancer 2019-11-29

The present observational, multicenter, retrospective study investigated the efficacy and tolerability of lacosamide in controlling secondary epileptic seizures patients with brain tumors Spain. Data from medical records ≥18 years age tumors, who had received at least one dose for seizure management between July 2013 November 2013, were collected. primary objectives to assess effectiveness lacosamide. 39 (mean age, 54.1 years; 66.7% male) collected, where two main reasons initiation...

10.3892/ol.2017.5988 article EN Oncology Letters 2017-04-05
Coming Soon ...